Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

被引：35

作者：

Chen, LY ^{[1
]}

Eriksson, N ^{[1
]}

Gwilliam, R ^{[1
]}

Bentley, D ^{[1
]}

Deloukas, P ^{[1
]}

Wadelius, M ^{[1
]}

机构：

[1] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England

来源：

BLOOD | 2005年 / 106卷 / 10期

关键词：

D O I：

10.1182/blood-2005-04-1711

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3673 / 3674

页数：2

共 10 条

[1] MECHANISM OF ACTION OF WARFARIN - WARFARIN AND METABOLISM OF VITAMIN-K [J].

BELL, RG ;

MATSCHINER, JT ;

SADOWSKI, JA .

BIOCHEMISTRY, 1972, 11 (10) :1959-+

[2] The vitamin K-dependent carboxylase [J].

Berkner, KL .

JOURNAL OF NUTRITION, 2000, 130 (08) :1877-1880

[3] ANTICOAGULANT-RELATED BLEEDING - CLINICAL EPIDEMIOLOGY, PREDICTION, AND PREVENTION [J].

LANDEFELD, CS ;

BEYTH, RJ .

AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :315-328

[4] Identification of the gene for vitamin K epoxide reductase [J].

Li, T ;

Chang, CY ;

Jin, DY ;

Lin, PJ ;

Khvorova, A ;

Stafford, DW .

NATURE, 2004, 427 (6974) :541-544

[5] Compound heterozygous mutations in the γ-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors [J].

Rost, S ;

Fregin, A ;

Koch, D ;

Compes, M ;

Müller, CR ;

Oldenburg, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (04) :546-549

[6] Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 [J].

Rost, S ;

Fregin, A ;

Ivaskevicius, V ;

Conzelmann, E ;

Hörtnagel, K ;

Pelz, HJ ;

Lappegard, K ;

Seifried, E ;

Scharrer, I ;

Tuddenham, EGD ;

Müller, CR ;

Strom, TM ;

Oldenburg, J .

NATURE, 2004, 427 (6974) :537-541

[7] Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity [J].

Shikata, E ;

Ieiri, I ;

Ishiguro, S ;

Aono, H ;

Inoue, K ;

Koide, T ;

Ohgi, S ;

Otsubo, K .

BLOOD, 2004, 103 (07) :2630-2635

[8] Common VKORC1 and GGCX polymorphisms associated with warfarin dose [J].

Wadelius, M ;

Chen, LY ;

Downes, K ;

Ghori, J ;

Hunt, S ;

Eriksson, N ;

Wallerman, O ;

Melhus, H ;

Wadelius, C ;

Bentley, D ;

Deloukas, P .

PHARMACOGENOMICS JOURNAL, 2005, 5 (04) :262-270

[9] Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors [J].

Wadelius, M ;

Sörlin, K ;

Wallerman, O ;

Karlsson, J ;

Yue, QY ;

Magnusson, PKE ;

Wadelius, C ;

Melhus, H .

PHARMACOGENOMICS JOURNAL, 2004, 4 (01) :40-48

[10] Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase [J].

Wu, SM ;

Stafford, DW ;

Frazier, LD ;

Fu, YY ;

High, KA ;

Chu, K ;

SanchezVega, B ;

Solera, J .

BLOOD, 1997, 89 (11) :4058-4062

← 1 →